- Home
- BKYI vs CPHI Comparison
BKYI vs CPHI Comparison
Compare BKYI & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKYI
- CPHI
- Stock Information
- Founded
- BKYI 1993
- CPHI N/A
- Country
- BKYI United States
- CPHI China
- Employees
- BKYI N/A
- CPHI N/A
- Industry
- BKYI Computer Software: Prepackaged Software
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- BKYI Technology
- CPHI Health Care
- Exchange
- BKYI Nasdaq
- CPHI Nasdaq
- Market Cap
- BKYI 3.8M
- CPHI 4.5M
- IPO Year
- BKYI 1997
- CPHI N/A
- Fundamental
- Price
- BKYI $0.72
- CPHI $1.50
- Analyst Decision
- BKYI
- CPHI
- Analyst Count
- BKYI 0
- CPHI 0
- Target Price
- BKYI N/A
- CPHI N/A
- AVG Volume (30 Days)
- BKYI 239.0K
- CPHI 107.1K
- Earning Date
- BKYI 06-13-2025
- CPHI 05-14-2025
- Dividend Yield
- BKYI N/A
- CPHI N/A
- EPS Growth
- BKYI N/A
- CPHI N/A
- EPS
- BKYI N/A
- CPHI N/A
- Revenue
- BKYI $6,929,571.00
- CPHI $4,528,929.00
- Revenue This Year
- BKYI $25.12
- CPHI N/A
- Revenue Next Year
- BKYI N/A
- CPHI N/A
- P/E Ratio
- BKYI N/A
- CPHI N/A
- Revenue Growth
- BKYI N/A
- CPHI N/A
- 52 Week Low
- BKYI $0.52
- CPHI $1.20
- 52 Week High
- BKYI $3.68
- CPHI $4.10
- Technical
- Relative Strength Index (RSI)
- BKYI 36.02
- CPHI 36.02
- Support Level
- BKYI $0.66
- CPHI $1.30
- Resistance Level
- BKYI $0.84
- CPHI $1.81
- Average True Range (ATR)
- BKYI 0.09
- CPHI 0.30
- MACD
- BKYI 0.01
- CPHI -0.07
- Stochastic Oscillator
- BKYI 45.45
- CPHI 17.65
About BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.